Showing results (1191-1200 of 1,205) with videos related to

Sort By:
Pageof 121
Biorxiv : the Preprint Server for Biology|January 13, 2025
CEBPA repression by MECOM blocks differentiation to drive aggressive leukemiasTravis J Fleming, Mateusz Antoszewski, Sander Lambo, et al.
Blood|September 24, 2025
CEBPA repression by MECOM blocks differentiation to drive aggressive leukemiasTravis J Fleming, Mateusz Antoszewski, Sander Lambo, et al.
JCI Insight|December 8, 2022
An ELF4 hypomorphic variant results in NK cell deficiencySandra Andrea Salinas, Emily M Mace, Matilde I Conte, et al.
Science Translational Medicine|July 27, 2022
Histamine production by the gut microbiota induces visceral hyperalgesia through histamine 4 receptor signaling in miceGiada De Palma, Chiko Shimbori, David E Reed, et al.
JAMA|October 20, 1999
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancerP A Rowlings, S F Williams, K H Antman, et al.
Journal of Medicinal Chemistry|August 5, 2016
Tyrosine Kinase Inhibitors. 20. Optimization of Substituted Quinazoline and Pyrido[3,4-d]pyrimidine Derivatives as Orally Active, Irreversible Inhibitors of the Epidermal Growth Factor Receptor FamilyJeff B Smaill, Andrea J Gonzales, Julie A Spicer, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 17, 2026
Compounded effects on wetland greenhouse gas fluxes from climate change and water management along a saline to freshwater gradientCheryl L Doughty, Qing Ying, Eric Ward, et al.
JAMA Network Open|November 6, 2024
Decision Support Intervention and Anticoagulation for Emergency Department Atrial Fibrillation: The O'CAFÉ Stepped-Wedge Cluster Randomized Clinical TrialDavid R Vinson, E Margaret Warton, Edward J Durant, et al.
Molecular Cancer Therapeutics|July 9, 2008
Antitumor activity and pharmacokinetic properties of PF-00299804, a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitorAndrea J Gonzales, Kenneth E Hook, Irene W Althaus, et al.
Trials|April 2, 2023
Clinical decision support to Optimize Care of patients with Atrial Fibrillation or flutter in the Emergency department: protocol of a stepped-wedge cluster randomized pragmatic trial (O'CAFÉ trial)David R Vinson, Adina S Rauchwerger, Chandu A Karadi, et al.
Pageof 121